ArticleInternational journal of medical sciences2022

Erratum: PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum.

Peng Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.